Diabetes Obes Metab (2012) 14(8):694708
It minimizes the chance of calculation errors during the actual administration phase of a study
Quality of the peptide matters more than quantity
The research, led by renowned obesity researcher and Phenomix co-founder, Andres Acosta, MD, PhD, and presented by Thomas Fredrick, MD, marks an important step toward more personalized obesity care and improved clinical trial design to support drug development
Record what you feel, when, and how it impacts your day
Proteccin cardiovascular y renal: estudios recientes han encontrado que los medicamentos GLP-1 proporcionan beneficios cardiovasculares, como la reduccin del riesgo de un segundo evento cardiovascular importante